# Major Recall Alert: Hemochron® Jr. Whole Blood Microcoaguation System - ACT-LR Test Cuvette Recalled Due to Foreign Object Contamination
A critical recall has been issued for the Hemochron® Jr. Whole Blood Microcoaguation System - ACT-LR Test Cuvette after a customer reported finding a foreign object (a single-edge blade) inside a cartridge. While no adverse events have been reported, this contamination poses potential safety risks. Read on to understand the full details and how you can stay informed.
## Why This Recall is Important
Medical testing products like the Hemochron® Jr. Whole Blood Microcoaguation System - ACT-LR Test Cuvette are essential tools in healthcare settings. This specific product is used to measure blood clotting times, playing a pivotal role in patient care.
However, reports of foreign objects—like a single-edge blade—inside any medical product raise concerns about safety, manufacturing standards, and quality control protocols. While no injuries or adverse events have been reported to date, proactive steps are essential to ensure no patient is exposed to potential harm.
Healthcare professionals and facilities using Hemochron® products should act immediately to review the implications of this recall and prevent usage of any affected items in their stock.
## Details of the Recall
Key information about the recall includes:
- **Category**: Canada (CAN)
- **Brand**: Hemochron® Jr. Whole Blood Microcoaguation System
- **Product**: ACT-LR Test Cuvette
- **Reason for Recall**: A single-edge blade (foreign object) was found in one test cartridge by a customer. No reported injuries or adverse events.
- **Date Announced**: October 2023
- **Complaints**: One customer report prompted this recall.
The recall affects all healthcare facilities using this product, regardless of whether they have personally encountered an affected cartridge. Actions are being taken to investigate the issue and prevent similar events.
To ensure public safety, the manufacturer and health authorities encourage anyone who encounters this defective product to report it immediately.
For more details, visit the official recall notice from Health Canada: [Hemochron® Jr. Whole Blood Microcoaguation System Recall Notice](https://recalls-rappels.canada.ca/en/alert-recall/hemochronr-jr-whole-blood-microcoaguation-system-act-lr-test-cuvette).
## What You Should Do
If your clinic, lab, or healthcare setting uses the Hemochron® Jr. ACT-LR Test Cuvette, take the following steps:
- **Stop Use Immediately**: Remove all test cuvettes currently in use until you confirm their safety.
- **Inspect Products**: Check stock for visible defects or contamination, such as foreign objects.
- **Notify Authorities**: Report any issues directly to Health Canada or the device manufacturer.
- **Dispose Safely**: Follow proper disposal protocols for affected products to prevent harm.
- **Spread the Word**: Inform your staff and colleagues about this recall to avoid future risks.
Taking quick action is crucial for ensuring patient safety and maintaining the integrity of your healthcare practice.
## Stay Safe – Get Instant Recall Alerts
Recalls like this underscore the importance of staying informed about changes that could affect your health or business. Whether you're a healthcare provider or a concerned consumer, staying updated on safety alerts is vital.
Be proactive—download a reliable app that provides real-time recall notifications straight to your device. With automatic updates, you can ensure your patients and community are always protected.
Stay safe, stay informed, and act quickly when alerts happen. Bookmark this page, and don’t forget to spread awareness about this crucial recall.
For more recall details, visit the official source: [Hemochron® Jr. Recall - Official Health Canada Notice](https://recalls-rappels.canada.ca/en/alert-recall/hemochronr-jr-whole-blood-microcoaguation-system-act-lr-test-cuvette).